Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

9.8%

4 terminated/withdrawn out of 41 trials

Success Rate

87.1%

+0.6% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 27 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (41)

Showing 20 of 41 trials
NCT04904835Completed

Access HBV Assays - European Union (EU) Clinical Trial Protocol -

Role: lead

NCT07099001Not ApplicableCompleted

Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay

Role: collaborator

NCT06257628Withdrawn

MACE CDS Software Master Enrollment Protocol

Role: lead

NCT07217431Completed

Access BNP Clinical Performance Evaluation: Testing and Clinical Concordance Study

Role: lead

NCT04280497Not ApplicableRecruiting

Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis

Role: collaborator

NCT06379061Completed

Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts

Role: lead

NCT05296590Active Not Recruiting

Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia

Role: collaborator

NCT06624293Completed

Access BNP Clinical Enrollment Study

Role: lead

NCT06885528Not Yet Recruiting

Adult MDW Dual Cut-Off Accuracy Study

Role: lead

NCT04971343Completed

Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol

Role: lead

NCT06267742Active Not Recruiting

Clinical Trial to Evaluate MDW for Early Detection of Sepsis

Role: lead

NCT06289868Completed

Access Anti-HAV and Access Anti-HAV IgM Assays EU Clinical Trial Protocol (HAV-EU-11-23)

Role: lead

NCT05819762Completed

Evaluation of ClearLLab LS Screening Panel

Role: lead

NCT06691477Completed

A Cut-off Value Study of N-terminal Brain Natriuretic Peptide (Chemiluminescence Method)

Role: lead

NCT06658379Recruiting

Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture

Role: collaborator

NCT05304728Enrolling By Invitation

Sepsis Clinical Decision Support [CDS] Master Enrollment Study Protocol

Role: lead

NCT05467449Completed

DxFLEX 10C Clinical Study

Role: lead

NCT03734172Completed

Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB)

Role: collaborator

NCT04169815Completed

Access Natriuretic Peptide Assay(s) Pivotal - Emergency Department Subject Enrollment and Specimen Collection

Role: lead

NCT04804306Completed

Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC

Role: lead